Article
Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library.
Antiviral research - 1 Nov 2017
Hernandez-Morales Ilane, Geluykens Peggy, Clynhens Marleen, Strijbos Rudy, Goethals Olivia, Megens Sarah, Verheyen Nick, Last Stefaan, McGowan David, Coesemans Erwin, De Boeck Benoît, Stoops Bart, Devogelaere Benoit, Pauwels Frederik, Vandyck Koen, Berke Jan Martin, Raboisson Pierre, Simmen Kenneth, Lory Pedro, Van Loock Marnix
Abstract excerpt
Dengue is the most important mosquito-transmitted viral disease and a major global health concern. Over the last decade, dengue virus (DENV) drug discovery and development has intensified, however, this has not resulted in approved DENV-specific antiviral treatments yet. DENV and hepatitis C virus (HCV) belong to the same Flaviviridae family and, in contrast to DENV, antiviral treatments for HCV have been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
